Product Information

ARIPIPRAZOLE 30 MG TABLET is a generic product labeled by Ascend Laboratories, LLC, priced at $0.1828 per EA under NDC 67877043503. Its NADAC has been published 359 times since Jan 1, 2020.

FDA first approved this application on Feb 21, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ARIPIPRAZOLE 30 MG TABLET

Aripiprazole
$0.1828per EA

Strength

30 mg/1

NDC

67877043503

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

ARIPIPRAZOLE

Approval Type

Generic (ANDA)

FDA Application

ANDA207105

FDA Approved

2/21/2019

TE Code

AB

On Market Since

2/27/2019

Pharmacological Classes

Price Statistics

The NADAC for ARIPIPRAZOLE 30 MG TABLET has been published 359 times since Jan 1, 2020, and over the history we have for it it has declined 56.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1828 per EA
All-time high$0.4586 (Apr 15, 2020)
All-time low$0.1365 (Nov 20, 2024)
52-week high$0.1828
52-week low$0.1567
Median price$0.2474
Average price$0.2481
Largest weekly change+41.4% (Aug 21, 2024)
Weeks tracked359
Tracking sinceJan 1, 2020

Price History

1W

0.0%

1M

+5.4%

3M

+16.6%

6M

+5.3%

1Y

+5.5%

3Y

-16.0%

5Y

-40.6%

All

-56.6%

Generic Alternatives

The matcher finds 14 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ARIPIPRAZOLE 30 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ARIPIPRAZOLE 30 MG TABLET, manufactured by Ascend Laboratories, LLC, is $0.1828 per EA (NDC 67877043503), effective Nov 11, 2026.

How has the price of ARIPIPRAZOLE 30 MG TABLET changed over time?

Over the history we have for it, the NADAC for ARIPIPRAZOLE 30 MG TABLET has declined 56.6%. It has been tracked across 359 weekly CMS publications since Jan 1, 2020.

What are the highest and lowest recorded NADAC prices for ARIPIPRAZOLE 30 MG TABLET?

Since Jan 1, 2020, the NADAC for ARIPIPRAZOLE 30 MG TABLET has ranged from a low of $0.1365 (Nov 20, 2024) to a high of $0.4586 (Apr 15, 2020), with a median of $0.2474 per EA.

Are there cheaper alternatives to ARIPIPRAZOLE 30 MG TABLET?

14 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ARIPIPRAZOLE 30 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures ARIPIPRAZOLE 30 MG TABLET?

ARIPIPRAZOLE 30 MG TABLET (NDC 67877043503) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.